Prevalence of Small Bowel Polyps in Patients With Sporadic Duodenal Adenomas | oneFAPvoice

welcome to oneFAPvoice

- a positively charged Familial Adenomatous Polyposis community.
  • join today!
active, not recruiting

Prevalence of Small Bowel Polyps in Patients With Sporadic Duodenal Adenomas

study id #: NCT02470416

condition: Polyps

status: active, not recruiting

purpose:

Little is known about the prevalence of small bowel polyps in patients with sporadic Duodenal/Ampullary polyps. The investigators aim to investigate the prevalence of small bowel polyps in patients with sporadic (ie not related to FAP or PJS) duodenal/ampullary adenomas by performing small bowel capsule endoscopy and comparing the results to those acquired from a control cohort undergoing VCE for accepted indication at our centre.

intervention: Small bowel video capsule endoscopy (VCE) GIVEN/COVIDIEN LTD

start date: October 2015

estimated completion: July 2018

last updated: July 4, 2019

phase of development: Not Available

size / enrollment: 177

study design:
Allocation: Non-Randomized
Intervention Model: Parallel Assignment
Masking: Open Label
Primary Purpose: Diagnostic

study description:
Investigation for suspected SB tumors is an acceptable indication for VCE. SB polyps occur frequently in patients with FAP/PJS and in patients with FAP, they are significantly more common in patients with Duodenal/Ampullary polyps. Little is known about the prevalence of small bowel polyps in patients with sporadic Duodenal/Ampullary polyps.
The primary hypothesis is that patients with sporadic (ie not related to FAP or PJS) duodenal/ampullary adenomas have a higher prevalence of small bowel polyps compared with patients undergoing VCE for various indications who have not had a duodenal polyp diagnosed or removed.
Patients who have had a previous diagnosis and/or treatment of a duodenal/ampullary polyp at Westmead hospital will receive VCE examination. Control population will consist of age matched controls having VCE for OGIB/IDA at Westmead hospital. Patients will be required to have had a documented colonoscopy within the previous three years. If colonoscopy was not performed within this time frame, the patient will have a colonoscopy as part of the study protocol.

primary outcomes:

  • Number of participants with sporadic (ie not related to FAP or PJS) duodenal/ampullary adenomas [Time Frame:24 months]

secondary outcomes:

  • Number of participants with presence and prevalence of colonic polyps [Time Frame:24 months]

inclusion criteria:

• Eligible Sexes:

• Cases - Patients who were diagnosed with or underwent resection of a duodenal adenoma/ampulloma at Westmead hospital between the years 2005-2014.
• Controls - Patients undergoing VCE procedure for the evaluation of obscure gastrointestinal bleeding (OGIB) or Iron deficiency anemia (IDA).

exclusion criteria:
• None

sponsor: Western Sydney Local Health District

trial center locations: Australia

The cookie settings on this website are set to "allow cookies" to give you the best browsing experience possible. If you continue to use this website without changing your cookie settings or you click "Accept" below then you are consenting to this.

Close